| I had the same experience as the author when I first started learning about clinical trials from the perspective of the software world. The amount of money invested in clinical trials and lack of visibility is staggering. We've companies that spend the entirety of their $100Ms in funding and not realized until month(s) after the fact when their accruals caught up! A lot of it is messed up and can be improved. Indeed, we've have more demand than we can service since we productized what we're working on at Condor (https://condorsoftware.notion.site/About-Condor-d8a466f7722e...). However, similar to what others have alluded, Chesterton's Fence is a relevant concept here (https://fs.blog/chestertons-fence/). It's critical to understand the rational reasons why the industry is so apparently messed up before you can fix them affectively. I wouldn't be working on the problem we're tackling today, if it weren't for my cofounder's deep knowledge across several disciplines in the industry. One thing that continues to make a meaningful impression on me is the mission driven motivation behind so many people working in the industry of all levels. Consistently from the chief scientist to the entry level accountant you hear people talk about how they tie their work to the patients. Many software companies say they are "changing lives," many life science workers can actually point to saving them. It's been a big motivating factor for my cofounder and I to realize the same companies we are helping extend R&D runway are the ones making cancer drugs for some of those close to us. Messy industry dynamics and backwards software means there are lots of BHAGs (https://www.jimcollins.com/concepts/bhag.html) to tackle. Always down to talk shop on clinical trial finance, software, or ways to collaborate with good people whose interest this piques! Contact in bio. |